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Tularemia, commonly prevalent in various regions of the northern side of the equator, is a zoonotic illness caused by Francisella tularensis. Among various Francisella tularensis species, subspecies tularensis is most pathogenic to human and included as category a biowarfare agent which can cause infection through aerosol, cut, injuries in skin and contact with tainted creatures. Right now, there is no approved vaccine is available for this very infectious intracellular pathogen. In this study, three Francisella proteins viz. FopA, GroEL and DnaK were cloned and expressed. The recombinant proteins were purified and utilized as a cocktail for immunization in mice. The ELISA results demonstrated that this cocktail elicited high antibody titres in sera of vaccinated animals. Among the IgG subtypes, IgG1 response was prevalent in immunized animals took after by IgG2. This indicated the induction of Th2 type immune responses against this cocktail a vaccine candidate. The investigation demonstrated that the blend of these three proteins has the potential as vaccine candidate for tularemia.  
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Introduction Francisella tularensis causes profoundly infectious zoonotic disease tularemia in humans. It is a non-spore forming, Gram-negative, an intracellular bacterium with low infectious dose (<10 CFU) and if left untreated, has mortality rate upto 60%. To begin with distinguished in ground squirrels in Tulare County of California in 1911, F. tularensis has included four perceived subspecies: tularensis, holarctica, mediasiatica, and novicida. Out of these, subspecies tularensis is viewed as the most virulent in humans, while subspecies holarctica is the reason for the majority of naturally happening instances of tularemia1.  Lower infective dose, simplicity of aerosolization, wide range of hosts and respiratory route of infection qualifies F. tularensis as an agent of option for bioterrorism2. A significant part of the exploration as of late on F. tularensis is centered around the advancement of an effective vaccine against it. Heretofore no authorized vaccine exists against this pathogen; despite the fact that an attenuated live immunization strain (LVS) has been utilized that gives incomplete protection to humans against respiratory challenge. Utilization of F. tularensis LVS 
as vaccine is full of limitations because of the questionable source of attenuation and worry about inversion to a virulent phenotype3. Albeit live attenuated vaccines demonstrate promising defensive impacts, current patterns in prophylaxis advancement, support subunit vaccines as opposed to live attenuated vaccine strains. Since Francisella is an intracellular pathogen, a Francisella subunit immunization needs to incite cell-mediated immunity notwithstanding antibodies4. For that reason, it is significant to build up another vaccine that will be sheltered and successful in instigating defensive enduring immune response against the most virulent strain of F. tularensis. At present, the core of F. tularensis vaccine advancement is on growing live attenuated and subunit vaccines. The subunit vaccine for F. tularensis is not available due to lack of identified Francisella antigens able to protect against the highly virulent subspecies tularensis. In this study, the potential of the cocktail of recombinant FopA, DnaK and GroEL proteins was evaluated. The individual protein was cloned and expressed in Escherichia coli. The proteins were purified to homogeneity and used for immunization in mice. The immune response in terms of specific IgGs and their isotypes for individual protein was determined. 
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Materials and Methods 
Ethics Statement All animal experiments were approved by the Institutional Animal Ethical Committee (IAEC) at Defense Research and Development Establishment (DRDE), Gwalior wide registration number 37/1999/CPCSEA and Institutional Biosafety Committee (IBSC) wide protocol number ISBC/12/BT/DVK/4.  Bacterial Cell Culture, Plasmids and Reagents F. tularensis type B LVS (NCTC 10857), obtained from Health Protection Agency, United Kingdom (UK) was cultivated on cysteine heart agar (Difco, Germany) supplemented with 9% sheep blood at 37°C for 48 h in BSL-3 laboratory, DRDE, Gwalior. Escherichia coli M15 (having kanamycin selection marker) (Qiagen, Germany) and E. coli BL21(DE3) (Novagen, Germany) were maintained on LB agar  (25 µg/ml kanamycin) and LB agar, respectively. pET28a (+) vector (Novagen, Germany) having kanamycin resistance marker was used to clone groEL and dnaK gene while pQE30 UA (Qiagen, Germany) having ampicillin resistance marker was used to clone the fopA gene.  Cloning of fopA, dnaK and groEL Recombinant Constructs in pET Vector Total genomic DNA of F. tularensis NCTC 10857 was isolated using GenEluteTM bacterial genomic DNA kit (Sigma-Aldrich, USA) as per manufacturer’s instruction. The polymerase chain reaction (PCR) was performed using programmable thermal cycler  (Bio-Rad, USA) using approximately 10 ng of template DNA. Target genes fopA, groEL and dnaK coding for the respective proteins were PCR amplified using forward and reverse primers specific for each gene (Table 1). The amplified fopA was purified using PCR clean up kit and ligated into pre linearized pQE30 UA vector in accordance with the manufacturer's instructions to further transform it in chemically competent E. coli M15 host cells. The 
transformants were selected on the media plates containing ampicillin (100 µg/ml) and kanamycin  (25 µg/ml). For cloning in pET28a(+) vector, both vector and PCR products of groEL and dnaK were double digested with restriction enzymes EcoRI and SacI (Fermentas, Canada). Both, digested pET28a(+) vector and gene were ligated and the ligation product was transformed into E. coli expression host BL21 (DE3) and the transformants were selected on LB agar plate supplemented with kanamycin. The presence of inserts was confirmed by the colony PCR (data not shown).  Expression and Purification of rFopA, rDnaK and rGroEL Recombinant proteins were expressed at 37°C after IPTG induction and rFopA protein was purified in denaturing conditions while rDnaK and rGroEL proteins were purified in native conditions using  Ni-NTA affinity columns (Qiagen, Germany) as described by the manufacturer. The purified recombinant proteins were dialyzed against Phosphate-buffer saline (PBS) and estimated by bicinchoninic acid (BCA) method using BCA kit (Sigma, USA). Purified proteins (2 µg/well) were separated by 12% SDS-PAGE. Since both cloning vectors have N terminal His-tag to the recombinant proteins, the presence of proteins was confirmed by western blotting with anti-His antibody.  Immunization of Mice Groups of six mice (female BALB/c) each weighing 20-25 gm received three doses of a cocktail of rFopA, rDnaK and rGroEL (10 µg of each  purified protein per mouse) was administered subcutaneously with aluminium hydroxide gel (0.35% in sterile PBS). Control group was immunized with PBS only. Mice were immunized on day 0 and boosted two more times on day 14 and day 21. One week after the final immunization, mice were bled and serum was separated for the study of the humoral immune response. The serum is stored at −20°C untill  further use.  
Table 1— Primers sequence of various Francisella genes 
Gene Primer Sequence (5’ - 3’) Tm (°C) Amplicon size  (in bp) Reference 
dnaK F -GAATTCATGGGAAAAATAATAGGTATAG R -GAGCTCTTATTTTTTGTCGTCTTCAAC 59.0 64.0 1,928 This study 
groEL F -GAATTCATGGCTGCAAAACAAGTTTTA R -GAGCTCTTACATCATGCCAGGCATA 64.0 68.0 1,624 This study 
fopA F-GCAGGTTCAGATAATATCGATACGTTAGC R-TTAGTTAGCTTCTTTAAGTGGAGCTGATACG 66.0 67.0 1,104 Hickey et al, 2011 
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IgG Antibody Response The end point titers of IgG antibodies were measured by enzyme-linked immunosorbent assay (ELISA) in the sera of immunized and control group animals. In brief, 96 well ELISA plates were coated individually with rFopA, rDnaK and rGroEL proteins using 100 ng/well of each antigen in 0.05 M carbonate buffer, pH 9.6. The coated plates were incubated overnight at 4°C. After washings with 0.05% Tween 20 in PBS (PBS-T), the plates were blocked with blocking solution (5% skim milk in PBS) incubated for 2 hr at 37°C. Plates were washed with PBS-T, and the test sera collected from immunized and control groups after first and second boosters were serially diluted in wells (100 μl/well) in triplicate. The plates were incubated for 1 hr at 37°C. After washings with PBS-T, plates were probed with rabbit anti-mouse horseradish peroxidase (HRP) labeled IgG (Dako, USA) at 1:1000 dilutions in PBS, incubated for 1 h at 37°C. The plates were washed and the reaction was developed with o-phenylenediamine dihydrochloride (OPD) tablet (Sigma-Aldrich, USA) and after 20 min stopped by 2 N H2SO4. The optical density (OD) was measured at 490 nm by a multimode plate reader (Biotek, USA).  IgG Isotyping In order to characterize the antibody isotypes, microtiter plates was coated with antigens corresponding to immunization groups (0.1 μg/well) and blocked with 5% skim milk in PBS. Sera (1:1000 in PBS) from immunized animals collected after the second booster were added in triplicate wells. Plate was incubated for 1 h at 37°C, washed and again 
incubated with goat anti-mouse isotype specific antibodies IgG1, IgG2a, IgG2b, IgG3 (Sigma-Aldrich, USA) at 1:1000 dilution for 1 h at 37°C. Detection of bound isotype specific antibodies was estimated with rabbit anti-goat IgG HRP conjugate (Dako, USA) at 1: 5000 dilution in PBS. The reaction was developed with OPD as substrate and stopped with 2 N H2SO4 and optical density (OD) was measured at 490 nm.  Results 
Cloning, Expression and Purification of fopA Gene in pQE30 UA Vector The PCR was standardized with the genomic DNA of F. tularensis NCTC 10857, employing primers for the amplification of 1.1 kb fopA gene at the annealing temperature of 65°C. The amplicon of fopA gene was purified by gel extraction and cloned in pQE30 UA expression vector under the control of T5 lac promoter using E. coli M15 host (Qiagen, Germany). Randomly, one PCR positive clone was selected for optimization of expression with respect to time of induction. SDS-PAGE analysis of expression profile of rFopA protein at different time interval showed an increase in the expression of 43 kDa protein after induction by 1 mM IPTG after 4 h of induction. The rFopA protein having histidine fusion tag was purified by Ni-NTA chromatography in denatured condition. Finally, after optimization rFopA protein was eluted with low pH of elution buffer containing 8 M urea (pH 4.5). SDS-PAGE analysis of different purified fractions showed three bands for rFopA protein in elutes and yield was found to be 30 mg/L of culture. The purified protein was characterized by western blot analysis with anti-His/HRP conjugate (Fig. 1).  
  Fig. 1 — (A) SDS-PAGE analysis of purified recombinant Francisella protein. M- Pre-stained protein marker; Lane 1- rFopA; Lane 2- rGroEL; Lane 3- rDnaK (2 µg of each); (B) Western blot analysis of the purified proteins with anti HIS antibody. M- Pre-stained protein marker; Lane 1- rDnak; Lane 2- rDnak; Lane 3- rGroEL. 
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Cloning, Expression and Purification of groEL and dnaK Genes in pET28a(+) Vector The groEL (1624 bp) and dnaK (1928 bp) genes were amplified using genomic DNA of F. tularensis NCTC 10857 strain and gene specific primers. Amplification PCR of groEL and dnaK genes was carried out at annealing temperatures of 65°C and 58°C, respectively. Amplicons of dnaK and groEL genes contain flanking restriction enzyme cutting site EcoRI at 5’ end and SacI at 3’ end. The groEL and dnaK genes were cloned into pET28a(+) vector by digesting both the genes and pET28a(+) circular vector using EcoRI and SacI restriction enzymes. The confirmed positive clone screened by colony PCR was used for the expression of rGroEL and rDnaK protein. The expression of the individual gene was optimized using 1 mM concentration of IPTG for 2 hr to overnight at 37ºC. Maximum expression was found to be 4 h after induction. The purification was carried out under native conditions. The 35 mg of recombinant DnaK protein per litre of culture (4 h induced) and 28 mg of recombinant GroEL protein per litre of culture (4 h induced) was obtained with purity to near homogeneity as revealed by Coomassie stained SDS-PAGE gel. The purified proteins were characterized by western blot analysis with anti-His-HRP conjugate and the single brown coloured band developed on nitrocellulose membrane confirmed the presence of 6X His tag containing recombinant proteins. All the recombinant proteins were  dialysed against PBS and SDS-PAGE analysis was performed to check the purity of proteins. The analysis revealed only a single band for each protein after dialysis (Fig. 1).  Humoral Immune Response Elicited by Recombinant Proteins  After successful immunization schedule, mice were bled on day 28. After the sera separation, the antibody titer in all the sera samples raised against recombinant 
antigens was determined by indirect ELISA. IgG subtyping was also performed.  Total IgG Titers To evaluate the IgG endpoint titers in the immunized group, total IgG were measured against rFopA, rDnaK and rGroEL from the pooled sera samples collected on seven days after the second booster. The mean absorbance ±2 S.D. (standard deviation) from sera of control group assayed at  1 : 100 dilutions was set as the cut-off value for the assays. Figure 2A shows antibody titers of pooled sera from 6 animals with individual recombinant antigen. Highest antibody titre was elicited against rDnaK protein (1 : 512000), followed by rFopA (1 : 256000) and rGroEL (1 : 128000).   IgG Isotyping Due to the strong antibody response, IgG isotyping analysis was performed from the pooled sera samples collected from all the immunized mice groups seven days after the second booster to determine the predominant isotypes of IgG antibodies produced by mice in response to immunization. The mean absorbance ±2 SD from sera of control group assayed at 1 : 1000 dilutions was set as cut-off value for the assays. Prominent levels of all four isotypes of IgG, i.e., IgG1, IgG2a, IgG2b and IgG3 were observed in immunized group (Fig. 2B) in comparison to control group. Among the IgG subclasses IgG1 showed the highest levels, although IgG2a and IgG2b levels were also very high. IgG3 levels were the lowest.  Discussion F. tularensis, the causative agent of disease tularemia, is a facultative, intracellular, Gram-negative coccobacillus. The severity of tularemia disease relies upon the course of the disease, dose and virulence of the strain1. Among the different types of 
  Fig. 2 — (A) Individual recombinant protein specific antibody titres of rFopA+rDnaK+rGroEL immunized mice serum; (B) Profile of IgG subclasses in sera from of rFopA+rDnaK+rGroEL immunized mice. 
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tularemia disease, respiratory tularemia is a noteworthy health concern, since the inability to initiate antibiotic treatment without delay can lead to high mortality rates. Tularemia has increased scientific consideration in view of its potential as a biowarfare weapon4. Unfortunately, notwithstanding such a great amount of research on Francisella, researchers have yet to generate a safe and convincing tularemia vaccine. Killed whole cell preparation and live attenuated vaccines were developed but could not be preceded because of safety and efficacy concerns. The most encouraging approach is the advancement of recombinant protein based subunit vaccine. Lack of a correlate of protection and the inadequate protection against respiratory infection caused by type A  F. tularensis remain major obstruction for endorsement of LVS as vaccine5. Therefore, scientists have been making endeavours for developing a safe vaccine that absolutely protects against respiratory tularemia. In the present study, three immunodominant proteins of F. tularensis LVS to be specific FopA, GroEL and DnaK were chosen as potential vaccine candidates. All these three proteins were observed to be immunogenic in a huge number of the immunoproteomic studies related to Francisella6-9. The recombinant FopA protein incorporated into liposomes indicated humoral immunity and protected naïve mice against LVS challenge but not with the type A strain10. FopA epitope peptides alongside Tul4 peptides conjugating with CpG could adequately improve the immune response in vitro and in vivo11. GroEL and DnaK producing recombinant Listeria monocytogenes had not been able to evoke sufficient protection against intranasal lethal challenge with LVS or aerosolized Schu S412. F. tularensis DnaK and GroEL are able to recall long-lasting CD4 and CD8 T-cell responses in humans13 and a significant cell-mediated response was seen against GroEL in mice14. Interestingly, F. tularensis GroEL was shown to have adjuvant like activity15. It is fascinating that chaperone proteins have been proposed to have adjuvant activity leading them to be immunostimulatory, which could potentially impact an immune response. So it is hypothesized that by combining heat shock proteins, GroEL and DnaK, with FopA can enhance the efficacy of this outer membrane protein. In light of the extent of IgG response employing indirect ELISA, mice sera distinguished rFopA and 
rDnaK antigens as the major immunodominant antigens. In vivo studies in mice revealed GroEL induced low IgG response in contrast to FopA and DnaK (Fig. 2A). The high antibody responses to FopA and DnaK antigen observed in the F. tularensis infected mice sera of the present study revealed the ready accessibility of these antigens to the host immune system. In this study, sera from rFopA + rDnaK + rGroEL immunized mice elicited a mixed type of (Th1 and Th2) immune response (Fig. 2B). Hyperimmune sera from intraperitoneally immunized mice presented high levels of IgG1, IgG2a, IgG2b and IgG3 response with a predominant IgG1 (Th2-associated) and IgG2b (Th1-associated) subtypes as compared to IgG2a (Th1-associated) and IgG3 levels (Th1-associated) in comparison to control sera16. Concoction of rFopA + rDnaK + rGroEL can be a promising vaccine candidate for the prevention of tularemia as revealed by the high titers of IgG antibodies with predominance of IgG1 in sera of immunized animals. The findings obtained under the present objective reveal that rFopA + rDnaK + rGroEL, as a vaccine candidate, had significantly augmented the antibody response with an increase in IgG2a and IgG1. Hence, vaccine candidate, rFopA + rDnaK + rGroEL, has the potential to evoke a strong humoral immune response. However, challenge test is necessary against virulent strain for evaluating the vaccine efficacy. 
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